Skip to main content
Back to 8VC

8VC's Biotechnology Portfolio

Browse 42 Biotechnology companies funded by 8VC. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
42
Total Funding in Biotechnology
$6.2B

Biotechnology Portfolio Companies (42)

Export
BiotechnologyTherapeutics

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein modifications.

Cambridge, United States
September 2022
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsMedical

Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.

San Francisco, United States
September 2021
$3.0B
Series A

Founder Contacts

30,000+ verified contacts

Big DataBiopharmaBiotechnologyLife ScienceMedical

Concerto Biosciences measures, maps, and utilizes microbes to create therapies and products for agriculture and human health industries.

Cambridge, United States
September 2024
Non-equity Assistance

Founder Contacts

30,000+ verified contacts

Biotechnology

Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies.

Cambridge, United States
September 2024
$25.0M
Grant

Founder Contacts

30,000+ verified contacts

AppsBiotechnologyElectronic Health Record (EHR)GeneticsHealth CarePersonal Health

Color is a healthcare delivery platform that offers cancer prevention, screening programs, and healthcare services for people.

South San Francisco, United States
August 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyManufacturingProduct ResearchSustainability

MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.

Emeryville, United States
July 2024
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Foster City, United States
July 2024
$25.0M
Corporate Round

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedicalTherapeutics

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

San Mateo, United States
July 2022
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.

Alameda, United States
June 2023
$100.0M
Series D

Founder Contacts

30,000+ verified contacts

Biotechnology

Portal Biotech is a biotechnology company specializing in advanced proteomics and metabolomics through single-molecule detection.

London, United Kingdom
June 2025
$37.1M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

South San Francisco, United States
May 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsTherapeutics

Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.

Philadelphia, United States
May 2026
$43.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

ProteinQure is a biotech company that designs peptide-based therapeutics and drug delivery systems using AI.

Toronto, Canada
May 2026
$1.8M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalTherapeutics

SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.

San Francisco, United States
May 2025
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

Cambridge, United States
May 2026
$122.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsManufacturingMedical Device

Acutus Medical develops medical technologies to treat complex cardiac arrhythmia.

Carlsbad, United States
April 2022
$35.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth DiagnosticsLife Science

Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.

San Francisco, United States
April 2024
$95.0M
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Los Angeles, United States
April 2022
$80.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceTherapeutics

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

Waltham, United States
April 2026
$40.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Amber Therapeutics develops the next-generation of bioelectrical therapies.

London, United Kingdom
March 2026
Non-equity Assistance

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

San Francisco, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGeneticsIndustrial AutomationInnovation ManagementLife ScienceMachine LearningSoftware

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Redwood City, United States
February 2022
$200.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsLife ScienceOncologyPharmaceutical

Xilis is an oncology and precision health company that provides technologies to diagnoses cancer.

Durham, United States
April 2025
$19.4M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyManufacturing

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

Oakland, United States
March 2025
$70.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyGenerative AILife SciencePharmaceutical

We are making biology programmable to transform health and sustainability for the benefit of all.

London, United Kingdom
February 2025
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

Elegen is a biotechnology company that develops microfluidic technology.

San Carlos, United States
May 2024
$35.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

SURGE Therapeutics seeks to dramatically improve cancer patient survival by disrupting cancer immunotherapy is deployed.

Cambridge, United States
July 2023
$32.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.

San Francisco, United States
January 2023
$9.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMedical Device

Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy.

Galway, Ireland
January 2026
$21.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceManufacturingMedicalTherapeutics

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

South San Francisco, United States
January 2026
$257.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth Care

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

San Francisco, United States
December 2022
$10.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife Science

HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.

Cambridge, United States
November 2022
$16.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.

South San Francisco, United States
November 2025
$300K
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

PathAI develops AI software and digital pathology systems used in diagnostic workflows, clinical research, and drug development.

Boston, United States
January 2022
$100.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMachine LearningMedicalPharmaceutical

Model Medicines uses human expertise and AI to accelerate the development of life-changing drugs at scale.

La Jolla, United States
November 2025
$3.3M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

La Jolla, United States
October 2025
$825.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

AnalyticsArtificial Intelligence (AI)BiotechnologyMachine LearningTherapeutics

Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.

New York, United States
October 2021
$215.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.

Menlo Park, United States
October 2022
$77.3M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Ness Ziona, Israel
December 2025
$3.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Redwood City, United States
November 2025
$350.0M
Post Ipo Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.

South San Francisco, United States
May 2025
$1.0M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareManufacturingOncologyPharmaceuticalTherapeuticsWellness

Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.

Boston, United States
December 2024
$48.1M
Series A

Founder Contacts

30,000+ verified contacts

Explore 8VC's Full Portfolio

View all companies funded by 8VC across every industry and funding stage.

View Full 8VC Portfolio